Chart Industries, Inc.  

(Public, NASDAQ:GTLS)   Watch this stock  
Find more results for GTLS
76.90
-0.67 (-0.86%)
Apr 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 76.49 - 78.08
52 week 72.92 - 130.85
Open 77.42
Vol / Avg. 221,535.00/415,551.00
Mkt cap 2.34B
P/E 29.66
Div/yield     -
EPS 2.59
Shares 30.47M
Beta 2.46
Inst. own 105%
May 22, 2014
Chart Industries Inc Annual Meeting of Stockholders - 9:00AM EDT - Add to calendar
Apr 29, 2014
Q1 2014 Chart Industries Inc Earnings Conference Call - 10:30AM EDT - Add to calendar
Apr 29, 2014
Q1 2014 Chart Industries Inc Earnings Release - 9:30AM EDT - Add to calendar
Feb 25, 2014
Q4 2013 Chart Industries Inc Earnings Conference Call
Feb 25, 2014
Q4 2013 Chart Industries Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 8.49% 7.42%
Operating margin 13.10% 11.55%
EBITD margin - 14.98%
Return on average assets 7.08% 6.26%
Return on average equity 12.64% 11.46%
Employees 4,842 -
CDP Score - -

Address

Suite 300 One Infinity Corporate Centre Drive
GARFIELD HEIGHTS, OH 44125-5370
United States - Map
+1-440-7531490 (Phone)
+1-302-6745266 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Chart Industries, Inc. is an independent global manufacturer of engineered equipment used in the production, storage and end-use of hydrocarbon and industrial gases. The Company supplies engineered equipment used throughout the global liquid gas supply chain. It operates in three segments: energy and chemicals (E&C), distribution and storage or (D&S), and biomedical. The E&C and D&S segments manufacture products used primarily in energy-related and general industrial applications, such as the separation, liquefaction, distribution and storage of hydrocarbon and industrial gases. Through its BioMedical segment, it supplies cryogenic and other equipment used in the storage and distribution of biological materials and oxygen, used primarily in the medical, biological research and animal breeding industries.

Officers and directors

Samuel F. Thomas Chairman of the Board, President, Chief Executive Officer
Age: 61
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Michael F. Biehl Chief Financial Officer, Executive Vice President, Treasurer
Age: 57
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Kenneth J. Webster Vice President, Chief Accounting Officer, Controller
Age: 50
Bio & Compensation  - Reuters
Matthew J. Klaben Vice President, General Counsel, Secretary
Age: 43
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Michael Press Lead Independent Director
Age: 65
Bio & Compensation  - Reuters
W. Douglas Brown Independent Director
Age: 67
Bio & Compensation  - Reuters
Richard E. Goodrich Independent Director
Age: 69
Bio & Compensation  - Reuters
Steven W. Krablin Independent Director
Age: 62
Bio & Compensation  - Reuters
James M. Tidwell Independent Director
Age: 66
Bio & Compensation  - Reuters